References
- C.O. Kappe, Microwave dielectric heating in synthetic organic chemistry, Chem. Soc. Rev. 37 (2008), pp. 1127–1139. doi:https://doi.org/10.1039/b803001b.
- C.O. Kappe and D. Dallinger, The impact of microwave synthesis on drug discovery, Nat. Rev. Drug Discov. 5 (2006), pp. 51–63. doi:https://doi.org/10.1038/nrd1926.
- N.C. Desai, K. Bhatt, D.J. Jadeja, H.K. Mehta, V.M. Khedkar, and D. Sarkar, Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids, Drug Dev. Res. (2021). doi:https://doi.org/10.1002/ddr.21872.
- N.C. Desai, G.M. Kotadiya, K.A. Jadeja, K.N. Shah, A.H. Malani, V. Manga, and T. Vani, Synthesis, antitubercular, antimicrobial activities and molecular docking study of quinoline bearing dihydropyrimidines, Bioorg. Chem. 115 (2021), pp. 105173. doi:https://doi.org/10.1016/j.bioorg.2021.105173.
- N.C. Desai, K. Bhatt, J. Monapara, U. Pandit, and V.M. Khedkar, Conventional and microwave-assisted synthesis, antitubercular activity, and molecular docking studies of pyrazole and oxadiazole hybrids, ACS Omega 6 (2021), pp. 28270–28284. doi:https://doi.org/10.1021/acsomega.1c04411.
- H.A. Aziz, G.A.I. Moustafa, S.H. Abbas, G. Hauk, V.S. Krishna, D. Sriram, J.M. Berger, and G.E.-D.A. Abuo-Rahma, New fluoroquinolones/nitric oxide donor hybrids: Design, synthesis and antitubercular activity, Med. Chem. Res. 28 (2019), pp. 1272–1283. doi:https://doi.org/10.1007/s00044-019-02372-y.
- D. Ramesh, A. Joji, B.G. Vijayakumar, A. Sethumadhavan, M. Mani, and T. Kannan, Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis, Eur. J. Med. Chem. 198 (2020), pp. 112358. doi:https://doi.org/10.1016/j.ejmech.2020.112358.
- H. Verma, S. Choudhary, M. Kumara, and O. Silakari, In silico guided design of non-covalent inhibitors of DprE1: Synthesis and biological evaluation, SAR QSAR Environ. Res. 32 (2021), pp. 333–352. doi:https://doi.org/10.1080/1062936X.2021.1900390.
- Y.J. Tan, M. Li, G.A. Gunawan, S.A. Nyantakyi, T. Dick, M.L. Go, and Y. Lam, Amide–amine replacement in indole-2-carboxamides yields potent mycobactericidal agents with improved water solubility, ACS Med. Chem. Lett. 12 (2020), pp. 704–712. doi:https://doi.org/10.1021/acsmedchemlett.0c00588.
- R. Das and D.K. Mehta, Evaluation and docking study of pyrazine containing 1, 3, 4-oxadiazoles clubbed with substituted azetidin-2-one: A new class of potential antimicrobial and antitubercular, Drug Res. 71 (2021), pp. 26–35. doi:https://doi.org/10.1055/a-1252-2378.
- P. Singh, T. Saha, P. Mishra, M.K. Parai, S. Ireddy, M.S. Lavanya Kumar, S. Krishna, S.K. Kumar, V. Chaturvedi, S. Sinha, and M.I. Siddiqi, Additional synthesis on thiophene-containing trisubstituted methanes (TRSMs) as inhibitors of M. tuberculosis and 3D-QSAR studies, SAR QSAR Environ. Res. 27 (2016), pp. 883–909. doi:https://doi.org/10.1080/1062936X.2016.1243575.
- A.Q.A. Nadaf, M.S. Najare, M. Garbhagudi, S. Mantur, M.G.S. Sunagar, S.J. Gaonkar, and I.A.M. Khazi, Synthesis of 6‐[4‐(4‐propoxyphenyl) piperazin‐1‐yl]‐9h‐purine derivatives as antimycobacterial and antifungal agents: In vitro evaluation and in silico study, Chem. Biodivers. 17 (2020), pp. e2000053. doi:https://doi.org/10.1002/cbdv.202000053.
- N.C. Desai, H.K. Mehta, and J.P. Harsora, 2-Pyridone quinoline hybrids as potent antibacterial and antifungal agents, Indian J. Chem. Sect. B 60 (2021), pp. 261–266.
- N.C. Desai, K.A. Jadeja, D.J. Jadeja, V.M. Khedkar, and P.C. Jha, Design, synthesis, antimicrobial evaluation, and molecular docking study of some 4-thiazolidinone derivatives containing pyridine and quinazoline moiety, Synth. Commun. 51 (2020), pp. 952–963.
- S.K. Verma, R. Verma, S. Verma, Y. Vaishnav, S.P. Tiwari, and K.P. Rakesh, Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review, Eur. J. Med. Chem. 209 (2020), pp. 112886. doi:https://doi.org/10.1016/j.ejmech.2020.112886.
- O.O. Ajani and K.T. Iyaye, Recent advances on oxadiazole motifs: Synthesis, reactions and biological activities, Mediterr. J. Chem. 10 (2020), pp. 418–452. doi:https://doi.org/10.13171/mjc10502005121200ooa.
- S. Gershon, G. Sakalis, and P.A. Bowers, Mesoridazine—a pharmacodynamic and pharmacokinetic profile, J. Clin. Psychopharmacol. 42 (1981), pp. 463–469.
- N.C. Desai, H. Somani, A. Trivedi, K. Bhatt, L. Nawale, V.M. Khedkar, and D. Sarkar, Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1, 3, 4-oxadiazole derivatives as potential antitubercular agents, Bioorg. Med. Chem. Lett. 26 (2016), pp. 1776–1783. doi:https://doi.org/10.1016/j.bmcl.2016.02.043.
- A. Khan, and D. Sarkar, A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli, J. Microbiol. Methods 73 (2008), pp. 62–68. doi:https://doi.org/10.1016/j.mimet.2008.01.015.
- A. Khan, S. Sarkar, and D. Sarkar, Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages, Int. J. Antimicrob. Agents 32 (2008), pp. 40–45. doi:https://doi.org/10.1016/j.ijantimicag.2008.02.022.
- R. Singh, L.U. Nawale, M. Arkile, U.U. Shedbalkar, S.A. Wadhwani, D. Sarkar, and B.A. Chopade, Chemical and biological metal nanoparticles as antimycobacterial agents: A comparative study, Int. J. Antimicrob. Agents 46 (2015), pp. 183–188. doi:https://doi.org/10.1016/j.ijantimicag.2015.03.014.
- S. Sarkar, and D. Sarkar, Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model, J. Biomol. Screen 17 (2012), pp. 966–973. doi:https://doi.org/10.1177/1087057112445485.
- U. Singh, S. Akhtar, A. Mishra, and D. Sarkar, A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents, J. Microbiol. Meth. 84 (2011), pp. 202–207. doi:https://doi.org/10.1016/j.mimet.2010.11.013.
- N.C. Desai, H.V. Vaghani, A.M. Jethawa, and V.M. Khedkar, In silico molecular docking studies of oxadiazole and pyrimidine bearing heterocyclic compounds as potential antimicrobial agents, Arch. Pharm. 354 (2021), pp. e2100134. doi:https://doi.org/10.1002/ardp.202100134.
- C. Vilchèze, H.R. Morbidoni, T.R. Weisbrod, H. Iwamoto, M. Kuo, J.C. Sacchettini, and W.R. Jacobs Jr, Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis, J. Bacteriol. 182 (2000), pp. 4059–4067. doi:https://doi.org/10.1128/JB.182.14.4059-4067.2000.
- R.A. Friesner, Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes, J. Med. Chem. 49 (2006), pp. 6177–6196. doi:https://doi.org/10.1021/jm051256o.
- R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.H. Knoll, M. Shelley, J.K. Perry, D.E. Shaw, P. Francis, and P.S. Shenkin, Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem. 47 (2004), pp. 1739–1749. doi:https://doi.org/10.1021/jm0306430.
- T.A. Halgren, R.B. Murphy, R.A. Friesner, H.S. Beard, L.L. Frye, W.T. Pollard, and J.L. Banks, Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem. 47 (2004), pp. 1750–1759. doi:https://doi.org/10.1021/jm030644s.
- K. Takayama, C. Wang, and G.S. Besra, Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis, Clin. Microbiol. Rev. 18 (2005), pp. 81–101. doi:https://doi.org/10.1128/CMR.18.1.81-101.2005.